Chemical Evaluation of Betula Species in Japan. III. Constituents of Betula maximowicziana. (Q104913239)

http://api.crossref.org/works/10.1248%2Fcpb.44.1748

main subject

Betula maximowicziana

1 reference

(3R,5S,8R,9R,10R,12R,13R,14R,17R)-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-1,2,3,5,6,7,9,11,12,13,15,16-dodecahydrocyclopenta[a]phenanthrene-3,12,17-triol

1 reference

3,4,5-trimethoxyphenyl-1-O-beta-D-apiofuranosyl-(1->6)-O-beta-D-glucopyranoside

1 reference

[(3S,5S,8R,9R,10R,13R,14R,17S)-17-[(E,2S)-2,7-dihydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate

1 reference

[(3R,5S,8R,9R,10R,12R,13R,14R,17R)-3,17-dihydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-1,2,3,5,6,7,9,11,12,13,15,16-dodecahydrocyclopenta[a]phenanthren-12-yl] acetate

1 reference

(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate

1 reference

3alpha-(alpha-L-Rhamnopyranosyloxymethyl)-4beta-(3,5-dimethoxy-4-hydroxyphenyl)-5,7-dimethoxy-6-hydroxytetralin-2beta-methanol

1 reference

1 reference

[(3R,5S,8R,9R,10R,12R,13R,14R,17S)-3-hydroxy-17-[(2S,5R)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-12-yl] acetate

1 reference

1 reference

(3R,5S,8R,9R,10R,13S,14R,17R)-17-[(2S,5R)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,4,8,10,14-pentamethyl-1,2,3,5,6,7,9,11,12,13,15,16-dodecahydrocyclopenta[a]phenanthrene-3,17-diol

1 reference

1 reference

5,7,4'-Trihydroxy-3,6-dimethoxyflavone

1 reference

4,17-Dihydroxy-3-methoxytricyclo[12.3.1.12,6]nonadeca-1(17),2,4,6(19),14(18),15-hexaen-9-one

1 reference

(+)-catechin 7-O-beta-D-xyloside

1 reference

Lupane-3beta,20,28-triol

1 reference

[(3S,5S,8R,9R,10R,13R,14R,17S)-17-[(E,2S)-2,7-dihydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-3-(4-hydroxyphenyl)prop-2-enoate

1 reference

PGQCELLZPXFKMZ-NMKFIHLRSA-N

Oleanolic acid 3-acetate

1 reference

1 reference

1 reference

(1R,3aR,3bR,5aS,7R,9aR,9bR,11R,11aR)-1-hydroxy-1-[(2S,5R)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-7-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-dodecahydrocyclopenta[a]phenanthren-11-yl acetate

1 reference

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(9S,11S)-3,11,17-trihydroxy-9-tricyclo[12.3.1.12,6]nonadeca-1(17),2,4,6(19),14(18),15-hexaenyl]oxy]oxane-3,4,5-triol

1 reference

(4aS,6aR,6aS,6bR,8aS,10S,12aR,14bS)-10-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid

1 reference

(3R,5S,8R,9R,10R,13R,14R,17S)-17-[(2S,5R)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol

1 reference

[(3R,5S,8R,9R,10R,12R,13R,14R,17R)-3,17-dihydroxy-17-[(2S,5R)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,4,8,10,14-pentamethyl-1,2,3,5,6,7,9,11,12,13,15,16-dodecahydrocyclopenta[a]phenanthren-12-yl] acetate

1 reference

1 reference

Dammarenediol II 3-O-caffeate

1 reference

3-(3,4-Dihydroxyphenyl)acrylic acid 20,28-dihydroxylupan-3beta-yl ester

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

Hiroyuki FUCHINO

1

1 reference

http://api.crossref.org/works/10.1248%2Fcpb.44.1748

Tetsuya SATOH

series ordinal

2

1 reference

http://api.crossref.org/works/10.1248%2Fcpb.44.1748

Nobutoshi TANAKA

series ordinal

3

1 reference

http://api.crossref.org/works/10.1248%2Fcpb.44.1748

publication date

1996

1 reference

stated in

Crossref

retrieved

16 September 2022

full work available at URL

https://www.jstage.jst.go.jp/article/cpb1958/44/9/44_9_1748/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1248/cpb.44.1748?email=unpaywall_01@example.com

published in

Chemical & Pharmaceutical Bulletin

1 reference

http://api.crossref.org/works/10.1248%2Fcpb.44.1748

volume

44

1 reference

http://api.crossref.org/works/10.1248%2Fcpb.44.1748

page(s)

1748-1753

1 reference

http://api.crossref.org/works/10.1248%2Fcpb.44.1748

issue

9

1 reference